Intravascular large B-cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: Report of a case successfully treated with a CHOP/rituximab combination regimen

Clinical Lymphoma

Volumn 6, Issue 1, 2005, Pages 46-49

  Jardin, Fabrice ^a   Callonnec, Françoise ^a   Contentin, Nathalie ^a   Picquenot, Jean Michael ^a   Gueit, Isabelle ^b   Héron, Françoise ^b   Bastard, Christian ^a   Tilly, Hervé ^a  

^a CENTRE HENRI BECQUEREL   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Combination therapy; Diffuse large B cell lymphoma; Intravascular lymphoma

Indexed keywords

CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; RITUXIMAB; VINCRISTINE;

AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; BONE MARROW TUMOR; BRAIN VENTRICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELL CLONE; CEREBELLUM TENTORIUM; DRUG EFFICACY; DURA MATER; FOLLOW UP; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MENINGITIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PYREXIA IDIOPATHICA; SAGITTAL SINUS THROMBOSIS; SPLENOMEGALY; STANDARDIZATION; SUPERIOR SAGITTAL SINUS; TETRAPLOIDY; TUMOR CELL; TUMOR REGRESSION; VASCULAR TUMOR; WHITE MATTER; ANOREXIA; BONE MARROW METASTASIS; CANCER REGRESSION; CANCER STAGING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DISEASE FREE SURVIVAL; IMAGE ANALYSIS; KARNOFSKY PERFORMANCE STATUS; LABORATORY TEST; PHYSICAL EXAMINATION; PROGNOSIS; WEAKNESS; WEIGHT REDUCTION;

EID: 22944463836     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2005.n.027     Document Type: Article

References (22)

1. Jaffe E, Harris N, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyons; 2001:177-178.
2. Yegappan S, Coupland R, Arber DA, et al. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol 2001; 14:1147-1156.
3. Martin-Duverneuil N, Mokhtari K, Behin A, et al. Intravascular malignant lymphomatosis. Neuroradiology 2002; 44:749-754.
4. Liow K, Asmar P, Liow M, et al. Intravascular lymphomatosis: contribution of cerebral MRI findings to diagnosis. J Neuroimaging 2000; 10:116-118.
5. Williams RL, Meltzer CC, Smirniotopoulos JG, et al. Cerebral MR imaging in intravasculaf lymphomatosis. Am J Neuroradiol 1998; 19:427-431.
6. Calamia KT, Miller A, Shuster EA, et al. IntravascuJar lymphomatosis. A report of ten patients with central nervous system involvement and a review of the disease process. Adv Exp Med Biol 1999; 455:249-265.
7. Lapkuviene O, Forchetti D, Roepke JE. Unusual sites of involvement by hematologic malignancies. Case 1. Intravascular large B-cell lymphoma presenting with CNS symptoms. J Clin Oncol 2001; 19:3988-3991.
8. Kenez J, Barsi P, Majtenyi K, et al. Can intravascular lymphomatosis mimic sinus thrombosis? A case report with 8 months' follow-up and fatal outcome. Neuroradiology 2000; 42:436-440.
9. Nagami Y, Ishikura R, Takada Y, et al. A case of intravascular lymphomatosis with sinus thrombosis. Nippon Igaku Hoshasen Gakkai Zasshi 2003; 63:180-182.
10. Amagasaki K, Yamazaki H, Ohmori K, et al. Malignant intravascular lymphomatosis associatedwith venous stenosis. Case report. J Neurosurg 1999; 90:355-358.
11. Khoury H, Dalal BI, Nantel SH. Intravascular lymphoma presenting with bone marrow involvement and leukemic phase. Leuk lymphoma 2003; 44:1043-1047.
12. Estalilla OC, Koo CH, Brynes RK, et al. Intravascular large B-cell lymphoma. A report of five cases initially diagnosed by bone marrow biopsy. Am J Clin Pathol 1999; 112:248-255.
13. Ito M, Kim Y, Choi JW, et al. Prevalence of intravascular large B-cell lymphoma with bone marrow involvement at initial presentation. Int J Hematol 2003; 77:159-163.
14. Tsukadaira A, Okubo Y, Ogasawara H, et al. Chromosomal aberrations in intravascular lymphomatosis. Am J Clin Oncol 2002; 25:178-181.
15. Khoury H, Lestou VS, Gascoyne RD, et al. Multicolor karyotyping and clinicopathological analysis of three intravascular lymphoma cases. Mod Pathol 2003; 16:716-724.
16. Murase T, Nakamura S, Kawauchi K, et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 2000; 111:826-834.
17. DiGiuseppe JA, Nelson WG, Seifter EJ, et al. Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol 1994; 12:2573-2579.
18. Baehring JM, Longtine J, Hochberg FH. A new approach to the diagnosis and treatment of intravascular lymphoma. J Neurooncol 2003; 61:237-248.
19. Koizumi M, Nishimura M, Yokota A, et al. Successfull treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 27:1101-1103.
20. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346:235-242.
21. Han K, Haley JC, Carlson K, et al. Regression of cutaneous intravascular lymphoma with rituximab. Cutis 2003; 72:137-140.
22. Davis TS. Intravascular lymphoma presenting with cauda equine syndrome: treated with CHOP and rituxan. Leuk Lymphoma 2003; 44:887-888.